ClearPoint Neuro, Inc. Quarterly Debt-to-equity in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ClearPoint Neuro, Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q3 2024.
  • ClearPoint Neuro, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 61.8 %, a 2.03% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 61.8 -1.28 -2.03% Sep 30, 2024
Q2 2024 72.1 +17.7 +32.6% Jun 30, 2024
Q1 2024 75.1 +28 +59.6% Mar 31, 2024
Q4 2023 75.2 +32.9 +77.7% Dec 31, 2023
Q3 2023 63 +24.6 +64% Sep 30, 2023
Q2 2023 54.4 +13.1 +31.8% Jun 30, 2023
Q1 2023 47 +3.2 +7.3% Mar 31, 2023
Q4 2022 42.3 -9.65 -18.6% Dec 31, 2022
Q3 2022 38.4 -38.4 -50% Sep 30, 2022
Q2 2022 41.2 -68.3 -62.3% Jun 30, 2022
Q1 2022 43.8 -167 -79.2% Mar 31, 2022
Q4 2021 51.9 -1.33K -96.2% Dec 31, 2021
Q3 2021 76.8 -733 -90.5% Sep 30, 2021
Q2 2021 110 -280 -71.9% Jun 30, 2021
Q1 2021 211 +3.84 +1.86% Mar 31, 2021
Q4 2020 1.38K +1.22K +775% Dec 31, 2020
Q3 2020 810 +627 +342% Sep 30, 2020
Q2 2020 390 +160 +69.6% Jun 30, 2020
Q1 2020 207 -140 -40.3% Mar 31, 2020
Q4 2019 158 -71.2 -31.1% Dec 31, 2019
Q3 2019 183 +3.75 +2.09% Sep 30, 2019
Q2 2019 230 +80.9 +54.3% Jun 30, 2019
Q1 2019 347 +225 +184% Mar 31, 2019
Q4 2018 229 +59.1 +34.8% Dec 31, 2018
Q3 2018 180 -77.6 -30.2% Sep 30, 2018
Q2 2018 149 -394 -72.6% Jun 30, 2018
Q1 2018 122 +679 Mar 31, 2018
Q4 2017 170 +671 Dec 31, 2017
Q3 2017 257 +732 Sep 30, 2017
Q2 2017 542 +844 Jun 30, 2017
Q1 2017 -557 -270 -94.2% Mar 31, 2017
Q4 2016 -501 -200 -66.6% Dec 31, 2016
Q3 2016 -475 -127 -36.5% Sep 30, 2016
Q2 2016 -301 +18.3 +5.73% Jun 30, 2016
Q1 2016 -287 +54.9 +16% Mar 31, 2016
Q4 2015 -301 +44 +12.8% Dec 31, 2015
Q3 2015 -348 -101 -41% Sep 30, 2015
Q2 2015 -319 -40.7 -14.6% Jun 30, 2015
Q1 2015 -342 -33.1 -10.7% Mar 31, 2015
Q4 2014 -345 -3.45 -1.01% Dec 31, 2014
Q3 2014 -247 +68.3 +21.7% Sep 30, 2014
Q2 2014 -279 -10.1 -3.78% Jun 30, 2014
Q1 2014 -309 -105 -51.8% Mar 31, 2014
Q4 2013 -342 -188 -122% Dec 31, 2013
Q3 2013 -315 -180 -133% Sep 30, 2013
Q2 2013 -269 Jun 30, 2013
Q1 2013 -203 Mar 31, 2013
Q4 2012 -154 Dec 31, 2012
Q3 2012 -136 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.